Annual report pursuant to Section 13 and 15(d)

Equity Offerings (Details)

v3.23.1
Equity Offerings (Details)
 12 Months Ended
Aug. 24, 2022
STD (Db)
shares
Dec. 06, 2021
USD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
STD (Db)
shares
Dec. 31, 2021
USD ($)
shares
Equity Offerings:          
Proceeds from issuance of common shares, net of expenses     $ 39,291,945   $ 56,060,472
Aggregate purchase price for sale of shares     $ (70,000)   $ 45,462,626
Common stock issued under prospectus supplement dated December 6, 2021          
Equity Offerings:          
Number of shares issued during the period | shares     7,879,907 7,879,907  
Proceeds from issuance of common shares, net of expenses | Db       Db 39,487,960  
Common stock issued under prospectus supplement dated December 6, 2021 | At The Market Offering          
Equity Offerings:          
Authorized amount to be issued   $ 44,925,000      
Number of shares issued during the period | shares         10,490,188
Proceeds from issuance of common shares, net of expenses         $ 56.0
Common shares under prospectus supplement Dated August 24, 2022          
Equity Offerings:          
Authorized amount to be issued | Db Db 75,000,000        
Aggregate purchase price for sale of shares     $ 2,000,000.0    
Common shares available for future sale     71,300,000    
Common shares under prospectus supplement Dated August 24, 2022 | At The Market Offering | Series A Preferred Stock          
Equity Offerings:          
Preferred stock available for future sale     $ 25,000,000    
Common shares under prospectus supplement Dated August 24, 2022 | Overallotments | Series A Preferred Stock          
Equity Offerings:          
Number of shares issued during the period | shares 25,000,000